Design and experimental validation of a new radiolabeled analog of N-(3-hydroxy-4-methoxy-phenyl-methyl) ferrocene-carboxamide (VFC) targeting the TRPV1 receptor
The TRPV1 receptor has been recognized to play a role in cancer development, being overexpressed in prostate, breast, lung, and colon cancers. Since TRPV1 activation promotes cancer cell proliferation, invasion, and migration, TRPV1 antagonists may show potential as anti-cancer agents. Capsaicin and...
Saved in:
Main Authors: | Tesnim Dallegi (Author), Syrine Ben Hassen (Author), Nedra Rached (Author), Farah Menjji (Author), Roufaida Abassi (Author), Ameur Cherif (Author), Soumaya Kouidhi (Author), Mouldi Saidi (Author), Amor Mosbah (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gut microbiota, an emergent target to shape the efficiency of cancer therapy
by: Soumaya Kouidhi, et al.
Published: (2023) -
Molecular docking studies of N-substituted 4-methoxy-6-oxo-1-aryl-pyridazine-3-carboxamide derivatives as potential modulators of glutamate receptors
by: Hanna I. Severina, et al.
Published: (2020) -
Synthesis and Antiproliferative Activity of Novel Imipridone-Ferrocene Hybrids with Triazole and Alkyne Linkers
by: Tamás Czuczi, et al.
Published: (2022) -
Ferrocene-Based Drugs, Delivery Nanomaterials and Fenton Mechanism: State of the Art, Recent Developments and Prospects
by: Catia Ornelas, et al.
Published: (2023) -
Investigation of the Antitumor Effects of Tamoxifen and Its Ferrocene-Linked Derivatives on Pancreatic and Breast Cancer Cell Lines
by: Márton Kalabay, et al.
Published: (2022)